No effect of taurine on platelet aggregation in men with a predisposition to type 2 diabetes mellitus

Platelets

Volumn 16, Issue 5, 2005, Pages 301-305

  Spohr, Camilla ^a,d   Brons C ^a   Winther, K ^c   Dyerberg, J ^b   Vaag, A ^a  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d NONE   (Denmark)

Author keywords

ADP; Platelet aggregation; T2DM; Taurine

Indexed keywords

TAURINE;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE PREDISPOSITION; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADENOSINE DIPHOSPHATE; ADULT; AGED; BIOLOGICAL MARKERS; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DISEASE SUSCEPTIBILITY; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PREDIABETIC STATE; TAURINE;

EID: 21744440704     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100400020575     Document Type: Article

References (16)

1. Jacobsen JG, Smith LH. Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 1968;48:424-511.
2. Huxtable R. Physiological actins of taurine. Physiol Rev 1992;72:101-63.
3. Hansen SH. The role of taurine in diabetes and the development of diabetic complications. Diabetes-Metab Res Rev 2001;17:330-46.
4. Davi G, Catlano I, Averna M, Notarbartolo A, Strano A, Ciabattoni G, et al. Thromboxane in synthesis and platelet function in type 2 diabetes mellitus. New Engl J Med 1990;322:1769-74.
5. Mustard JF, Packam MA. Platelets and diabetes mellitus. New Engl J Med 1984;311:665-7.
6. Militante JD, Lombardini JB, Schaffer SW. The role of taurine in the pathogenesis of the cardiomyopathy of insulin-dependent diabetes mellitus. Cardiovasc Res 2000;46:393-402.
7. Frendo J, Koj A, Zgliczynski JM. Taurine in human blood platelets. Nature 1959;183:685-86.
8. Hayes KC, Pronczuk A, Addesa AE, Stephan ZF. Taurine modulates platelet aggregation in cats and humans. Am J Clin Nutr 1989;49:1211-16.
9. Miceli M, Bennardini F, Mattana A, Covarrubias J, Seghieri G, Franconi F. Taurine modifies platelet sensitivity to aperin, indomethacin, sodium nitroprusside and papaverine. Platelets 1992;3:265-69.
10. Raghu CN; Manikeri SR; Sheth UK, Dadkar VN. Probable mode of taurine action. Indian J Exp Biol 1982 Jun; 20(6):481-3.
11. Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, Mian M, et al. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 1995;61:1115-19.
12. De Luca G, Colpona PR, Caponetti A, Romano G, Di Benedetto A, Cucinotta D, et al. Taurine and osmoregulation: Platelet taurine content, uptake, and release in type 2 diabetic patients. Metabolism 2001;50(1):60-4.
13. De Luca G, Colpona PR, Caponetti A, Macaione A, Di Benedetto A, Cucinotta D, et al. Amino acid profile in platelets of diabetic patients. Metabolism 2001;59(7): 739-41.
14. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998;15(7):539-53.
15. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962;194:927-29.
16. Miglis M, Wilder D, Reid T, Bakaltcheva I. Effect of taurine on platelets and the plasma coagulation system. Platelets 2002;13:5-10.